Pharmaterials Ltd The Queen's Awards for Enterprise 2008
Home
Company Locations
Careers
Initiate a Project
Contact Us
Request A Brochure
Search Our Site
Home | COMPANY    |     POLYMORPHS/SALTS/CO-CRYSTALS    |     PREFORMULATION / FORMULATION    |     CONSULTANCY    |     GMP MANUFACTURE    |     PHYS PROPS    |     INHALATION    |    
Polymorphs/Salts/Co-crystals
Polymorph Screening Amorphous Content Screening Pharmaceutical Co-crystals Raman Mapping / Chemical Imaging Crystallisation of amorphous material Salt screening / salt selection Developability screen Formulation screen Pharmaceutical Quality by Design (QbD)

Pharmaceutical Developability Screen

 

When selecting the best candidate to take into full development, it is important to consider the key issues of:

  1. Chemical stability
  2. Solubility / dissolution rate
  3. Processability (melting point and others)

To ensure that the form is optimised we will assess the best form (salt or co-crystal) and make suggestions about the crystallinity, complexity, stability, dissolution and processing challenges for your active.

When taken in connection with our formulation screen you will rapidly be in a position to begin your development process with confidence.

First class information and advice - FAST.

  Home  |  Company  |  Polymorphs/Salts/Co-crystals  |  Preformulation / Formulation  |  Consultancy  |  GMP manufacture  |  Phys Props  |  Inhalation  |  News  |  Site Map
© 2007-2013 Pharmaterials Ltd, All rights reserved.       Website Development Company : UKWebCo.com